GlobeNewswire by notified

VisionH2 Announces Name Change and Forward Split

Share

JERSEY CITY, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Vision Hydrogen Corporation (OTCQB:VIHD) (“VisionH2” or the “Company”) announces that has approved a 1 for 2 forward stock split and a change of name to “Vision Energy Corporation”.

Effective as of the opening of market trading on November 8, 2022, the Company’s common stock will trade under the symbol VIHDD for 20 business days to designate the forward split, after which the Company will be assigned a new ticker symbol. The new CUSIP number for the Company’s common stock is 92837Y200. As a result of the Forward Split, the number of outstanding common shares will be increased from 21,048,776 to 42,097,552 and the number of authorized shares will be increased from 100,000,000 to 200,000,000.

It is not necessary for shareholders holding shares of the Company’s common stock in certificated form to exchange their existing stock certificates for new stock certificates of the Company in connection with the Forward Split, although shareholders may do so if they wish. Shareholders should direct any questions concerning the Forward Split to their broker or the Company’s transfer agent, VStock Transfer, at 212-828-8436.

About Vision Energy

Vision Energy is an integrated energy company developing assets and solutions for the commercial, industrial and transportation sectors. Leveraging its proven track-record in site and asset procurement, accelerating development and permitting processes, plant design, and grid integration to facilitate low-carbon energy production, supply and distribution. The Company pursues reliable offtake relationships and operating partnerships with energy industry participants and end users seeking carbon abatements across feedstock and fuels. Vision Energy is committed to providing low carbon energy solutions with the highest yield, and where possible, projects are designed to leverage existing gas and power infrastructure to integrate and facilitate import and or distribution of reduced-carbon energy to domestic and global supply chains.

Forward Looking Statements:

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “forecast,” “anticipate,” “believe,” “estimate,” “expect” and “intend,” among others. These forward-looking statements are based on current expectations, and actual results could differ materially. The Company does not undertake an obligation to update or revise any forward-looking statement. The information set forth herein speaks only as of the date hereof.

Vision Hydrogen Corporation/Investor Relations
95 Christopher Columbus Drive, 16th Floor
Jersey City, NJ 07302
551-298-3600 USA
https://visionh2.com/

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Heineken Holding N.V. reports on 2024 first-quarter trading24.4.2024 08:01:00 CEST | Press release

Amsterdam, 24 April 2024 – Heineken Holding N.V. (EURONEXT: HEIO; OTCQX: HKHHY) publishes its trading update for the first quarter of 2024. Key Highlights Revenue €8,184 million, up 7.2%Net revenue (beia) organic growth 9.4%; per hectolitre 4.9%Beer volume organic growth 4.7%Premium beer volume organic growth 7.3%Heineken® volume growth 12.9%Gross merchandise value captured via eB2B platforms +17%Outlook for the full year unchanged; operating profit (beia) expected to grow organically low- to high-single-digit. Heineken Holding N.V. engages in no activities other than its participating interest in Heineken N.V. and the management or supervision of and provision of services to that company. Financial Summary Throughout this report figures refer to quarterly performance unless otherwise indicated. Revenue in the first quarter was €8.2 billion, up 7.2%. Net revenue (beia) was €6.8 billion, up 9.4% organically. Total consolidated volume increased 4.3% and net revenue (beia) per hectolitre

Heineken N.V. reports on 2024 first-quarter trading24.4.2024 08:00:00 CEST | Press release

Amsterdam, 24 April 2024 – Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) publishes its trading update for the first quarter of 2024. Key Highlights Revenue €8,184 million, up 7.2%Net revenue (beia) organic growth 9.4%; per hectolitre 4.9%Beer volume organic growth 4.7%Premium beer volume organic growth 7.3%Heineken® volume growth 12.9%Gross merchandise value captured via eB2B platforms +17%Outlook for the full year unchanged; operating profit (beia) expected to grow organically low- to high-single-digit. CEO Statement Dolf van den Brink, Chairman of the Executive Board / CEO, commented: "As we maintained focus on our EverGreen priorities, we had an encouraging start to 2024. All regions grew volume and net revenue, and we continued to see a sequential improvement in the performance of the business, growing in line or ahead of the category in the majority of our markets. This quarter was boosted by an earlier Easter and cycling negative one-off effects from last year. Top-line delivery w

Pharming Group to report first quarter 2024 financial results on May 824.4.2024 08:00:00 CEST | Press release

Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) first quarter 2024 financial results, for the period ended March 31, on Wednesday, May 8, 2024. Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 am EDT on May 8, 2024. To participate in the conference call, please register in advance using the link below. Once registered, dial-in information and a unique PIN will be provided, allowing access to the call. Conference call registration: Please note, the Company will only take questions from dial-in attendees. https://register.vevent.com/register/BI6f55067b569a46d7a67be9f94edefc95 To watch the live webcast, please register in advance using the link below. Webcast registration: https://edge.media-server.com/mmc/p/ov2ruv3b About Pharming Group N.V. Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company

EXEL Industries : Second quarter 2023–2024 sales: up 1.8%24.4.2024 07:55:00 CEST | Press release

Second quarter 2023-2024 sales: down 1.8% Varying sales performance across activities Q2 sales (January 2024–March 2024) 2022-20232023-2024Change (reported)Change (LFL*) Reported Reported €m % €m % AGRICULTURAL SPRAYING 147.7157.4 +9.7 +6.5% +12.0 +8.1% SUGAR BEET HARVESTERS 34.317.1 -17.2 -50.1% -17.1 -49.9% LEISURE 48.447.4 -1.0 -2.0% -4.4 -9.0% INDUSTRY 67.670.7 +3.1 +4.7% +3.3 +4.9%EXEL Industries Group297.9292.6 -5.3 -1.8% -6.2 -2.1% 6-month sales (October 2023–March 2024) 2022-20232023-2024Change (reported)Change (LFL*) Reported Reported €m % €m % AGRICULTURAL SPRAYING 236.8248.3 +11.6 +4.9% +17.0 +7.2% SUGAR BEET HARVESTERS 53.844.2 -9.6 -17.8% -8.5 -15.9% LEISURE 62.158.5 -3.6 -5.9% -8.8 -14.1% INDUSTRY 130.4141.7 +11.3 +8.7% +14.4 +11.0%EXEL Industries Group483.1492.7 +9.7 +2.0% +14.1 +2.9% * Like-for-like (LFL) = at constant consolidation scope and foreign exchange rates Second quarter 2023-2024 sales The EXEL Industries Group posted revenue of €292.6 million for the second q

Vistin Pharma ASA: First quarter 2024 financial results24.4.2024 07:44:00 CEST | Press release

Oslo, Norway, 24th of April 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2024. Revenue in the first quarter ended at MNOK 104 compared to MNOK 101 in Q1 2023. Sales volume in the quarter was up by 11% compared to Q1 2023. First quarter EBITDA ended at MNOK 20 compared to MNOK 14 in Q1 2023, representing a 45% increase. EBITDA positively affected by increased sales volume and product mix, partly offset by a one-time inventory adjustment of MNOK 7. The net profit ended at MNOK 7.7 for the first quarter of 2024. Net profit negatively affected with approx. MNOK 3 in the quarter by fair value of future FX cash flow hedging contracts (unrealized gain - no cash effect in quarter). Unplanned “wear and tear” maintenance/repair on Line 2 resulted in lower than planned production and sales volume in the first quarter. After the repair, line 2 has been producing according to plan from fiscal week 14. The first quarter conference call, which will be

HiddenA line styled icon from Orion Icon Library.Eye